Southampton lymphoma specialist who led the RATHL trial of PET-guided therapy in Hodgkin lymphoma and serves as NHS England's National Clinical Director for Cancer.
Peter Johnson is Professor of Medical Oncology at the University of Southampton and University Hospital Southampton, working within the Centre for Cancer Immunology, the UK's first dedicated cancer immunology centre. He was chief investigator of the RATHL trial, which established interim PET-CT guided de-escalation of chemotherapy in advanced Hodgkin lymphoma, and his research focuses on antibody and vaccine immunotherapy for lymphoma. He also serves as National Clinical Director for Cancer at NHS England.
| Title | Journal | Year |
|---|---|---|
| Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma | New England Journal of Medicine | 2016 |
For someone offered the test, these are the numbers that describe what a result means in an NHS population: about 1 in 100 tests came back positive each year, between 46 and 58 in 100 positives were cancer, and a negative result left about 1 in 100 with an undetected cancer within the year. The test found between a quarter and a third of all cancers diagnosed in a screening round, and about half to two thirds of the 12 cancer types it was designed to find. Whether finding them this way reduces late-stage diagnoses is the primary question, and this paper says only that the answer was no; the primary-endpoint paper had not appeared on Europe PMC by 23 September 2026.
A failure worth reading: the drug worked where patients could tolerate the regimen it was added to, and harmed where they could not. It is the strongest argument in lymphoma for designing first-line combinations around what an older patient can finish.
Shares Hodgkin lymphoma, Diffuse large B-cell lymphoma and the tags clinician-scientist, lymphoma.
Shares the tags clinician-scientist, immunotherapy.
Shares the tags clinician-scientist, immunotherapy.
Shares Hodgkin lymphoma, Diffuse large B-cell lymphoma and the tags clinician-scientist, lymphoma.
Shares Diffuse large B-cell lymphoma and the tags clinician-scientist, lymphoma.
Shares Diffuse large B-cell lymphoma and the tags clinician-scientist, lymphoma.
Shares Diffuse large B-cell lymphoma and the tags clinician-scientist, lymphoma.
Shares Diffuse large B-cell lymphoma and the tags clinician-scientist, lymphoma.